Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00412399 · ClinicalTrials.gov registry record
Job Adaptation in Patients With Rheumatoid Arthritis
A clinical trial, sponsored by Hospital for Special Surgery, New York.
- Completed
- Registry status
- 244
- Enrollment target
NCT00412399: Completed study, sponsored by Hospital for Special Surgery, New York.
NCT00412399 is a clinical trial that has completed, run by Hospital for Special Surgery, New York. The registered enrollment target is 244 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00412399 has completed, sponsored by Hospital for Special Surgery, New York.
- COMPLETED
- Registry status
- 244 participants
- Enrollment target
Study Summary
The specific aim of this study is to compare the rate of negative work role events in individuals with rheumatoid arthritis compared to healthy controls.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 244 participants |
| Start Date | 1999-06 |
| Est. Completion | 2001-10 |
What the finished NCT00412399 record still lists
NCT00412399 is an observational study that tracks outcomes without assigning an intervention. The registered 244 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00412399 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00412399 about?
NCT00412399 is a clinical study titled "Job Adaptation in Patients With Rheumatoid Arthritis". The specific aim of this study is to compare the rate of negative work role events in individuals with rheumatoid arthritis compared to healthy controls.
What is the current status of trial NCT00412399?
This trial is currently completed. The enrollment target is 244 participants. The study started on 1999-06. Estimated completion is 2001-10.
Who is sponsoring clinical trial NCT00412399?
This trial is sponsored by Hospital for Special Surgery, New York, which has 194 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02227251 · 244 participants · Phase 2
Selinexor (KPT-330) in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL)
- NCT04317534 · 244 participants · Phase 2
Adjuvant Pembrolizumab vs Observation Following Curative Resection for Stage I Non-small Cell Lung Cancer (NSCLC) With Primary Tumors Between 1-4 cm
- NCT04683250 · 244 participants · Phase 1
Study of RET Inhibitor TAS0953/HM06 in Patients With Advanced Solid Tumors With RET Gene Abnormalities
- NCT04686305 · 244 participants · Phase 1
Phase Ib Study of the Safety of T-DXd and Immunotherapy Agents With and Without Chemotherapy in Advanced or Metastatic HER2+, Non-squamous NSCLC
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia